Applied Cognition is driven by a seasoned team of entrepreneurs with decades of experience leading innovation in healthcare and related industries turning bold ideas into real-world breakthroughs. Backed by a world-renowned scientific advisory board and a top-tier drug development leadership team, together they tap into deep expertise across neuroscience, biotech, diagnostics, commercialization, translational research, clinical trials, data science, and AI.
Who We Are
Paul Dagum, MD PhD
CEO & Co-founder
Jake Winebaum
Executive Chairman & Co-founder
Our Collaborators
Our partners and collaborators feature a highly multidiscplinary team of physician scientists, neuroscientists, computer scientists, material scientists, microtechnology engineers, Alzheimer's neurologists and drug development veterans who come from some of the most highly reputed institutions in the nation.
We value strong partnerships with research institutions and we are committed to supporting high-quality scientific work. To ensure that funding is directed primarily toward advancing the research itself we maintain a maximum Indirect Cost (IDC) rate of 12% of eligible direct costs for sponsored research agreements. For questions on IDC eligibility or budget preparation, please contact info@appliedcognition.com.